Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in XLO — Xilio Therapeutics, Inc.

CIK 1107261 HOUSTON, TX
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$168,071
+$132,180 QoQ
Shares Held
17,544
+337.9% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 26 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. XLO ranks #86 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in XLO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $168,071 17,544
2025-12-31 $35,891 56,081
2025-09-30 $47,276 56,081
2025-06-30 $38,135 56,081
2025-03-31 $51,462 71,081
2024-12-31 $67,882 71,081
2024-09-30 $56,011 71,081
2024-06-30 $67,384 71,081
2024-03-31 $76,767 71,081
2023-12-31 $85,514 155,481
2023-09-30 $233,114 110,481
2023-06-30 $289,460 110,481
2023-03-31 $350,224 110,481
2022-12-31 $297,193 110,481
2022-09-30 $221,395 76,081